Entrada Therapeutics (TRDA) Insider Trading & Ownership → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free TRDA Stock Alerts $14.34 -0.02 (-0.14%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Entrada Therapeutics (NASDAQ:TRDA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.58%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$151,226.80Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.25 M Get TRDA Insider Trade Alerts Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TRDA Insider Buying and Selling by Quarter Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself Entrada Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/8/2024Peter S KimDirectorBuy2,276$14.04$31,955.04 4/8/2024Peter S KimDirectorBuy2,600$13.57$35,282.00 3/28/2024Peter S KimDirectorBuy1,512$13.75$20,790.00 3/25/2024Peter S KimDirectorBuy3,180$13.36$42,484.80 3/21/2024Peter S KimDirectorBuy704$13.24$9,320.96 3/19/2024Peter S KimDirectorBuy900$12.66$11,394.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/15/2024Dipal DoshiCEOSell1,000$15.00$15,000.00 1/16/2024Dipal DoshiCEOSell1,000$15.99$15,990.00 12/26/2023Kory James WentworthCFOSell94$16.67$1,566.98 12/22/2023Kory James WentworthCFOSell10,206$15.69$160,132.14 12/20/2023Dipal DoshiCEOSell1,000$15.00$15,000.00 11/13/2023Dipal DoshiCEOSell1,000$16.23$16,230.00 10/17/2023Dipal DoshiCEOSell1,000$15.00$15,000.00 9/13/2023Dipal DoshiCEOSell1,000$15.00$15,000.00 9/6/2023Kory James WentworthCFOSell950$13.48$12,806.00 9/6/2023Nathan J DowdenCOOSell972$13.47$13,092.84 9/6/2023Nerissa KreherInsiderSell892$13.48$12,024.16 8/14/2023Dipal DoshiCEOSell1,000$15.67$15,670.00 8/4/2023Nerissa KreherInsiderSell6,898$14.14$97,537.72 8/2/2023Nerissa KreherInsiderSell10,348$15.19$157,186.12 7/11/2023Kory James WentworthCFOSell3,884$18.00$69,912.00 7/10/2023Natarajan SethuramanInsiderSell3,026$18.00$54,468.00 7/10/2023Nathan J DowdenCOOSell3,200$18.00$57,600.00 6/22/2023Nathan J DowdenCOOSell7,097$16.02$113,693.94 6/21/2023Kory James WentworthCFOSell17,500$15.01$262,675.00 6/20/2023Nathan J DowdenCOOSell8,885$14.94$132,741.90 (Data available from 1/1/2013 forward) TRDA Insider Trading Activity - Frequently Asked Questions Who is on Entrada Therapeutics's Insider Roster? The list of insiders at Entrada Therapeutics includes Bros. Advisors Lp Baker, Dipal Doshi, John F Crowley, Kory James Wentworth, Natarajan Sethuraman, Nathan J Dowden, Nerissa Kreher, and Peter S Kim. Learn more on insiders at TRDA. What percentage of Entrada Therapeutics stock is owned by insiders? 7.58% of Entrada Therapeutics stock is owned by insiders. Learn more on TRDA's insider holdings. Which Entrada Therapeutics insiders have been buying company stock? The following insiders have purchased TRDA shares in the last 24 months: Bros. Advisors Lp Baker ($723,620.69), and Peter S Kim ($151,226.80). How much insider buying is happening at Entrada Therapeutics? Insiders have purchased a total of 130,238 TRDA shares in the last 24 months for a total of $874,847.49 bought. Which Entrada Therapeutics insiders have been selling company stock? The following insiders have sold TRDA shares in the last 24 months: Dipal Doshi ($820,721.49), Kory James Wentworth ($715,158.61), Natarajan Sethuraman ($125,766.00), Nathan J Dowden ($634,730.84), and Nerissa Kreher ($607,464.99). How much insider selling is happening at Entrada Therapeutics? Insiders have sold a total of 184,248 Entrada Therapeutics shares in the last 24 months for a total of $2,903,841.93 sold. More Insider Trading Tools from MarketBeat Related Companies: Fulcrum Therapeutics Insider Trades Theravance Biopharma Insider Trades Acelyrin Insider Trades Revance Therapeutics Insider Trades PepGen Insider Trades Esperion Therapeutics Insider Trades Lexicon Pharmaceuticals Insider Trades Korro Bio Insider Trades Heron Therapeutics Insider Trades Biomea Fusion Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:TRDA) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.